A dynamic, highly specialized molecular laboratory
CYNOGEN is focused on clinically proven FISH (fluorescence in situ hybridization) tests that are FDA approved and can aid in the detection and identification of certain cancers. Through laboratory collaboration, CYNOGEN offers a range of other molecular test methods.
The CYNOGEN laboratory is a state-of-the-art facility. Our areas of particular focus include the early detection of chromosomal changes that may signal cancer and the detection of gene rearrangements that identify patients most likely to respond to targeted therapies.
We strive to provide information to aid physicians in the management of their patients with cancer.